Who is sponsoring NCT03931122?

NCT03931122 is sponsored by Aga Khan University.

What drugs are being tested in NCT03931122?

Interventions in NCT03931122: Ear Size Based Method (Ambu® AuraOnce™ Laryngeal Mask Airway).

What condition does NCT03931122 study?

NCT03931122 studies Laryngeal Masks, Minors, Child, Pediatrics.

Is NCT03931122 still recruiting?

NCT03931122 is currently completed. Last updated 26 June 2024.

Last reviewed 2024-06-26 · How we verify

NCT03931122

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Comparison of Weight-based Versus External Ear-size Based Technique for Selection of Laryngeal Mask Airway in Pediatric Surgical Patients.

Completed NA Last updated 26 June 2024

What this trial tests

NA trial testing Ear Size Based Method (Ambu® AuraOnce™ Laryngeal Mask Airway) in Laryngeal Masks in 136 participants. Completed in 15 June 2024.

Timeline

11 December 2019

Primary endpoint
1 May 2024

15 June 2024

Quick facts

Lead sponsor	Aga Khan University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	prevention
Enrollment	136
Start date	11 December 2019
Primary completion	1 May 2024
Estimated completion	15 June 2024
Sites	1 location across Pakistan

Drugs / interventions tested

Ear Size Based Method (Ambu® AuraOnce™ Laryngeal Mask Airway)

Conditions studied

Laryngeal Masks — all drugs for Laryngeal Masks →
Minors — all drugs for Minors →
Child — all drugs for Child →
Pediatrics — all drugs for Pediatrics →

Sponsor

Aga Khan University

Who can join

Adults 6 Months to 18, any sex, with Laryngeal Masks or Minors. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Laryngeal Mask Airway (LMA) is widely used in pediatric surgical patients. The manufacturer recommends the size of LMA to be used in children should be based on actual body weight but this method has several limitations. To overcome these concerns, various alternatives have been tried by different researchers, one of them is external ear size for LMA size selection. Investigators therefore would like to know whether the external ear size based method can be used for LMA size selection in pediatric surgical patients in Pakistan.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Comparison of Weight-Based Versus External Ear-Size-Based Technique for Selection of Laryngeal Mask in Pediatric Surgical Patients: A Randomized Controlled Trial.
Ali MA, Salim B, Yousuf MS, Asghar S, et al · · 2026 · PMID 42005680 · DOI 10.1002/hsr2.72020

Verify or expand the search:

Other recruiting trials for Laryngeal Masks

Currently open trials in the same condition.

NCT06617403 — Pre-operative Characteristics for Prediction of Supraglottic Airway Failure Using Machine Learning (ERICA) · active not recruiting
NCT03502590 — IGEL Laryngeal Mask Airway Device Effectiveness in Irradiated Necks · NA · recruiting

Other Aga Khan University trials

Trials by the same sponsor.

NCT07475793 — Image Guided Genicular Nerve Radiofrequency Ablation for Chronic Knee Osteoarthritis · NA · not yet recruiting
NCT07197684 — Ultrasound Guided Pecs Block and Ketamine Infusion for Preventing Chronic Pain in Patients Undergoing Breast Cancer Surg · NA · not yet recruiting
NCT07356063 — Self-Efficacy Enhancement Using a Multicomponent Support Group for Caregivers of Children With DMD/SMA · NA · not yet recruiting
NCT07451951 — Effectiveness of SQLNS vs MQLNS for Prevention of Undernutrition in Children 6-12 Months · NA · not yet recruiting
NCT07357350 — Effectiveness of Pain Management Interventions in Patients With Abdominal and Pelvic Cancer · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03931122 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Aga Khan University
Last refreshed: 26 June 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03931122.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing